HK1245144A1 - Composition and method for inhibiting histone deacetylase - Google Patents
Composition and method for inhibiting histone deacetylaseInfo
- Publication number
- HK1245144A1 HK1245144A1 HK18104870.7A HK18104870A HK1245144A1 HK 1245144 A1 HK1245144 A1 HK 1245144A1 HK 18104870 A HK18104870 A HK 18104870A HK 1245144 A1 HK1245144 A1 HK 1245144A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- composition
- histone deacetylase
- inhibiting histone
- inhibiting
- deacetylase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01098—Histone deacetylase (3.5.1.98), i.e. sirtuin deacetylase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562197770P | 2015-07-28 | 2015-07-28 | |
US201562197745P | 2015-07-28 | 2015-07-28 | |
US201562197753P | 2015-07-28 | 2015-07-28 | |
US201562197757P | 2015-07-28 | 2015-07-28 | |
US201562197742P | 2015-07-28 | 2015-07-28 | |
US201562197782P | 2015-07-28 | 2015-07-28 | |
US201562197760P | 2015-07-28 | 2015-07-28 | |
PCT/US2016/044444 WO2017019850A1 (en) | 2015-07-28 | 2016-07-28 | Composition and method for inhibiting histone deacetylase |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1245144A1 true HK1245144A1 (en) | 2018-08-24 |
Family
ID=57885715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18104870.7A HK1245144A1 (en) | 2015-07-28 | 2018-04-13 | Composition and method for inhibiting histone deacetylase |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3328400A4 (en) |
JP (1) | JP2018524360A (en) |
CN (1) | CN107847525A (en) |
HK (1) | HK1245144A1 (en) |
TW (1) | TW201707713A (en) |
WO (1) | WO2017019850A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018144981A1 (en) * | 2017-02-06 | 2018-08-09 | StemBios Technologies, Inc. | Use of somatic stem cells for increasing autophagy |
CN112351786A (en) * | 2018-06-14 | 2021-02-09 | 4D制药研究有限公司 | Compositions comprising bacterial strains |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7737175B2 (en) * | 2007-06-01 | 2010-06-15 | Duke University | Methods and compositions for regulating HDAC4 activity |
TWI542691B (en) * | 2010-08-04 | 2016-07-21 | 幹細胞生物科技公司 | Somatic stem cells |
JP6495174B2 (en) * | 2012-12-06 | 2019-04-03 | ステムバイオス テクノロジーズ,インコーポレイテッド | LGR5 + somatic stem cells |
SI2970890T1 (en) * | 2013-03-14 | 2020-10-30 | The Brigham And Women's Hospital, Inc. | Compositions and methods for epithelial stem cell expansion and culture |
US20140377760A1 (en) * | 2013-06-24 | 2014-12-25 | StemBios Technologies, Inc. | Method for increasing number of stem cells in human or animal bodies |
-
2016
- 2016-07-28 TW TW105123920A patent/TW201707713A/en unknown
- 2016-07-28 EP EP16831341.9A patent/EP3328400A4/en not_active Withdrawn
- 2016-07-28 WO PCT/US2016/044444 patent/WO2017019850A1/en active Application Filing
- 2016-07-28 JP JP2018500783A patent/JP2018524360A/en active Pending
- 2016-07-28 CN CN201680043298.1A patent/CN107847525A/en active Pending
-
2018
- 2018-04-13 HK HK18104870.7A patent/HK1245144A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3328400A4 (en) | 2019-03-27 |
TW201707713A (en) | 2017-03-01 |
EP3328400A1 (en) | 2018-06-06 |
WO2017019850A1 (en) | 2017-02-02 |
CN107847525A (en) | 2018-03-27 |
JP2018524360A (en) | 2018-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL250355A0 (en) | Compounds and methods for inhibiting histone demethylases | |
HK1252489A1 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
RS62639B1 (en) | Hetero-halo inhibitors of histone deacetylase | |
EP3209815A4 (en) | Corrosion inhibitors and related compositions and methods | |
IL249629A0 (en) | Histone demethylase inhibitors | |
GB201718801D0 (en) | Compositions and methods for inhibiting factor D | |
IL263360A (en) | Combinations comprising histone deacetylase inhibitors | |
IL251103A0 (en) | Histone demethylase inhibitors | |
EP4063358C0 (en) | Histone methyltransferase inhibitors | |
IL249339A0 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
IL251179A0 (en) | Histone demethylase inhibitors | |
EP3443141A4 (en) | Composition and method for inhibiting corrosion | |
EP3129373A4 (en) | Histone deacetylase inhibitors | |
IL267465A (en) | Histone deacetylase inhibitors | |
HK1252487A1 (en) | Histone deacetylase inhibitors and compositions and methods of use thereof | |
IL256438B (en) | Histone deacetylase inhibitors | |
GB201518674D0 (en) | Method for detecting nuleosomes containing histone modifications and variants | |
IL251184A0 (en) | Histone demethylase inhibitors | |
EP3397617A4 (en) | Histone demethylase inhibitors | |
HK1245144A1 (en) | Composition and method for inhibiting histone deacetylase | |
EP3383494A4 (en) | Histone deacetylase inhibitors | |
HK1210028A1 (en) | Composition and method for the protection of articular cartilage | |
GB201602008D0 (en) | Histone deacetylase | |
SG11201605336YA (en) | Composition and method for the protection of articular cartilage |